// App-Quantinova.ai

144 : Detection and genomic interrogation of circulating tumor cells (CTCs) and circulating tumor stem cells (CTSCs) from men with metastatic castration-resistant prostate cancer (mCRPC).

Researchers

Presenter

  • Terence W. Friedlander

Principal Investigators

  • Vy Ngo

  • Shaun Doty

  • Qiang Zhao

  • Huang Dong

  • Charles J. Ryan

  • Wen-Tien Chen

  • Pamela Paris

Medical Centers

  • St Marys Medical Center, San Francisco, CA

  • University of California, San Francisco, San Francisco, CA

  • Stony Brook University, Stony Brook, NY

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Metastatic castration-resistant prostate cancer

Biomarkers

  • Circulating tumor cells

  • Cluster of Differentiation 44

  • Epithelial Cell Adhesion Molecule

  • Folate Hydrolase 1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved